

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.97126924 |
| 2 | behavioral response to nicotine (GO:0035095) | 4.37963783 |
| 3 | nucleobase catabolic process (GO:0046113) | 4.05192984 |
| 4 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.93259831 |
| 5 | axoneme assembly (GO:0035082) | 3.63966324 |
| 6 | nonmotile primary cilium assembly (GO:0035058) | 3.63111981 |
| 7 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.57956265 |
| 8 | nephron tubule morphogenesis (GO:0072078) | 3.48776778 |
| 9 | nephron epithelium morphogenesis (GO:0072088) | 3.48776778 |
| 10 | postsynaptic membrane organization (GO:0001941) | 3.37321096 |
| 11 | intestinal cholesterol absorption (GO:0030299) | 3.29729041 |
| 12 | secondary heart field specification (GO:0003139) | 3.28978150 |
| 13 | heart field specification (GO:0003128) | 3.28978150 |
| 14 | snRNA transcription (GO:0009301) | 3.14375737 |
| 15 | negative regulation of sodium ion transport (GO:0010766) | 3.13202231 |
| 16 | opioid receptor signaling pathway (GO:0038003) | 3.12159359 |
| 17 | C4-dicarboxylate transport (GO:0015740) | 3.01546661 |
| 18 | body morphogenesis (GO:0010171) | 3.00718750 |
| 19 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.00231577 |
| 20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.97029366 |
| 21 | neuromuscular process controlling posture (GO:0050884) | 2.95519426 |
| 22 | cellular anion homeostasis (GO:0030002) | 2.91520810 |
| 23 | presynaptic membrane organization (GO:0097090) | 2.87225522 |
| 24 | synaptic transmission, cholinergic (GO:0007271) | 2.86651316 |
| 25 | startle response (GO:0001964) | 2.85496985 |
| 26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.83942892 |
| 27 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.80947714 |
| 28 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.80827469 |
| 29 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.79075284 |
| 30 | peristalsis (GO:0030432) | 2.78545347 |
| 31 | regulation of male gonad development (GO:2000018) | 2.78496593 |
| 32 | neuronal action potential propagation (GO:0019227) | 2.75409628 |
| 33 | regulation of synapse maturation (GO:0090128) | 2.75085516 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 2.74343970 |
| 35 | protein localization to cilium (GO:0061512) | 2.73925608 |
| 36 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.72643757 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 2.72025661 |
| 38 | negative regulation of macroautophagy (GO:0016242) | 2.71274297 |
| 39 | reverse cholesterol transport (GO:0043691) | 2.71081846 |
| 40 | specification of organ identity (GO:0010092) | 2.70408093 |
| 41 | neuromuscular synaptic transmission (GO:0007274) | 2.69673843 |
| 42 | presynaptic membrane assembly (GO:0097105) | 2.69200525 |
| 43 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.69199103 |
| 44 | positive regulation of synapse maturation (GO:0090129) | 2.68145475 |
| 45 | detection of light stimulus involved in visual perception (GO:0050908) | 2.67958145 |
| 46 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.67958145 |
| 47 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.67620464 |
| 48 | sulfate transmembrane transport (GO:1902358) | 2.67445743 |
| 49 | iron-sulfur cluster assembly (GO:0016226) | 2.66306224 |
| 50 | metallo-sulfur cluster assembly (GO:0031163) | 2.66306224 |
| 51 | renal tubule morphogenesis (GO:0061333) | 2.65001375 |
| 52 | cell migration in hindbrain (GO:0021535) | 2.63785062 |
| 53 | protein carboxylation (GO:0018214) | 2.63334870 |
| 54 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.63334870 |
| 55 | mechanosensory behavior (GO:0007638) | 2.62155629 |
| 56 | neuronal action potential (GO:0019228) | 2.61362624 |
| 57 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.60921581 |
| 58 | protein polyglutamylation (GO:0018095) | 2.60669155 |
| 59 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.57701330 |
| 60 | regulation of timing of cell differentiation (GO:0048505) | 2.56521328 |
| 61 | fucose catabolic process (GO:0019317) | 2.56079775 |
| 62 | L-fucose metabolic process (GO:0042354) | 2.56079775 |
| 63 | L-fucose catabolic process (GO:0042355) | 2.56079775 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 2.54742848 |
| 65 | protein-lipid complex remodeling (GO:0034368) | 2.54742848 |
| 66 | macromolecular complex remodeling (GO:0034367) | 2.54742848 |
| 67 | cellular response to ATP (GO:0071318) | 2.52465784 |
| 68 | auditory behavior (GO:0031223) | 2.51675330 |
| 69 | protein localization to synapse (GO:0035418) | 2.50688077 |
| 70 | dendritic spine morphogenesis (GO:0060997) | 2.49519120 |
| 71 | low-density lipoprotein particle remodeling (GO:0034374) | 2.49355871 |
| 72 | peptidyl-glutamic acid modification (GO:0018200) | 2.48142090 |
| 73 | synapse assembly (GO:0007416) | 2.47489154 |
| 74 | auditory receptor cell stereocilium organization (GO:0060088) | 2.47338174 |
| 75 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.45614800 |
| 76 | primary amino compound metabolic process (GO:1901160) | 2.45486671 |
| 77 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.45445156 |
| 78 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.44295754 |
| 79 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.42338311 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 2.42266120 |
| 81 | negative regulation of cell cycle arrest (GO:0071157) | 2.41131960 |
| 82 | valine metabolic process (GO:0006573) | 2.39130467 |
| 83 | membrane depolarization during action potential (GO:0086010) | 2.37666272 |
| 84 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.36975591 |
| 85 | phasic smooth muscle contraction (GO:0014821) | 2.35278708 |
| 86 | embryonic body morphogenesis (GO:0010172) | 2.35160187 |
| 87 | establishment of mitochondrion localization (GO:0051654) | 2.34168468 |
| 88 | synaptic transmission, glutamatergic (GO:0035249) | 2.30012597 |
| 89 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.29961552 |
| 90 | inositol phosphate catabolic process (GO:0071545) | 2.29715875 |
| 91 | neuron cell-cell adhesion (GO:0007158) | 2.29443537 |
| 92 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.29399014 |
| 93 | neuron recognition (GO:0008038) | 2.29049632 |
| 94 | cholesterol efflux (GO:0033344) | 2.28547260 |
| 95 | cornea development in camera-type eye (GO:0061303) | 2.27733634 |
| 96 | axonal fasciculation (GO:0007413) | 2.27486105 |
| 97 | lung epithelium development (GO:0060428) | 2.26621812 |
| 98 | sex determination (GO:0007530) | 2.25400434 |
| 99 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.24665740 |
| 100 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.22829110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.09637843 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.34977496 |
| 3 | * ZNF274_21170338_ChIP-Seq_K562_Hela | 3.31832235 |
| 4 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.45658139 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.39093127 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.20548100 |
| 7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.15915220 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.11475128 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.09257053 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.02313940 |
| 11 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.00475021 |
| 12 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90414925 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75693174 |
| 14 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.71575419 |
| 15 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.71101169 |
| 16 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.68841576 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.64390325 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61696917 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61515878 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.61183520 |
| 21 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.58142172 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.55674856 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.54005055 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.53485561 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.53235273 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.51451448 |
| 27 | ERA_21632823_ChIP-Seq_H3396_Human | 1.49058119 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48943755 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48221368 |
| 30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42954560 |
| 31 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.42873872 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40399340 |
| 33 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39845306 |
| 34 | * MYC_19829295_ChIP-Seq_ESCs_Human | 1.36632884 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35104614 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.32971740 |
| 37 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29788776 |
| 38 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.29525858 |
| 39 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.28864309 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27953065 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27344156 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27274190 |
| 43 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.26523991 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25535142 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.24743149 |
| 46 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.24224048 |
| 47 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.21412533 |
| 48 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.21278301 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19585397 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19308011 |
| 51 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.19219543 |
| 52 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19199340 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17959255 |
| 54 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16910587 |
| 55 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.15666551 |
| 56 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15666551 |
| 57 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.15386915 |
| 58 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11559380 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.11496981 |
| 60 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11280891 |
| 61 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.11186955 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09779925 |
| 63 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09627410 |
| 64 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09302070 |
| 65 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09302070 |
| 66 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09105605 |
| 67 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.08149428 |
| 68 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.04745006 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03574647 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02812262 |
| 71 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.99711044 |
| 72 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98591987 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 0.98343138 |
| 74 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97950215 |
| 75 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.97910608 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96770950 |
| 77 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96667835 |
| 78 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.96344668 |
| 79 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96293928 |
| 80 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.96117694 |
| 81 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.95782040 |
| 82 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.95556155 |
| 83 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93318170 |
| 84 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.92415003 |
| 85 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91635864 |
| 86 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.90762149 |
| 87 | NCOR_22424771_ChIP-Seq_293T_Human | 0.90434815 |
| 88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90101247 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89175049 |
| 90 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88124776 |
| 91 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.87572725 |
| 92 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.86429350 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85910880 |
| 94 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.84879131 |
| 95 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.84806010 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84776440 |
| 97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84753546 |
| 98 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.84298470 |
| 99 | * AR_19668381_ChIP-Seq_PC3_Human | 0.83562553 |
| 100 | P300_19829295_ChIP-Seq_ESCs_Human | 0.83213968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003122_maternal_imprinting | 3.35516442 |
| 2 | MP0003195_calcinosis | 3.32938125 |
| 3 | MP0005394_taste/olfaction_phenotype | 2.75994702 |
| 4 | MP0005499_abnormal_olfactory_system | 2.75994702 |
| 5 | MP0008789_abnormal_olfactory_epithelium | 2.68425649 |
| 6 | MP0005360_urolithiasis | 2.65289115 |
| 7 | MP0002909_abnormal_adrenal_gland | 2.41844477 |
| 8 | MP0000566_synostosis | 2.33662258 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 2.20290350 |
| 10 | MP0003787_abnormal_imprinting | 2.16322580 |
| 11 | MP0005365_abnormal_bile_salt | 2.11830589 |
| 12 | MP0003646_muscle_fatigue | 2.11072882 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.09244049 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.02810372 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 1.95043262 |
| 16 | MP0004133_heterotaxia | 1.89346766 |
| 17 | MP0009745_abnormal_behavioral_response | 1.87542500 |
| 18 | MP0009046_muscle_twitch | 1.84852870 |
| 19 | MP0005423_abnormal_somatic_nervous | 1.82112049 |
| 20 | MP0006292_abnormal_olfactory_placode | 1.79825370 |
| 21 | MP0003121_genomic_imprinting | 1.76926285 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.76142865 |
| 23 | MP0010329_abnormal_lipoprotein_level | 1.74619471 |
| 24 | MP0003880_abnormal_central_pattern | 1.67932346 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.66354109 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.66184338 |
| 27 | MP0001486_abnormal_startle_reflex | 1.65955529 |
| 28 | MP0002064_seizures | 1.64103786 |
| 29 | MP0005379_endocrine/exocrine_gland_phen | 1.63288420 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.60274286 |
| 31 | MP0003635_abnormal_synaptic_transmissio | 1.55558554 |
| 32 | MP0004270_analgesia | 1.55339381 |
| 33 | MP0002572_abnormal_emotion/affect_behav | 1.54762305 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.53839645 |
| 35 | MP0002254_reproductive_system_inflammat | 1.50815945 |
| 36 | MP0001984_abnormal_olfaction | 1.49128192 |
| 37 | MP0001529_abnormal_vocalization | 1.46377063 |
| 38 | MP0002063_abnormal_learning/memory/cond | 1.44702440 |
| 39 | MP0002938_white_spotting | 1.43611991 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.41497392 |
| 41 | MP0002272_abnormal_nervous_system | 1.41122349 |
| 42 | MP0004043_abnormal_pH_regulation | 1.39475436 |
| 43 | MP0000631_abnormal_neuroendocrine_gland | 1.38671502 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.30984281 |
| 45 | MP0000778_abnormal_nervous_system | 1.28882389 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.26940066 |
| 47 | MP0002876_abnormal_thyroid_physiology | 1.22026310 |
| 48 | MP0006276_abnormal_autonomic_nervous | 1.20474104 |
| 49 | MP0008872_abnormal_physiological_respon | 1.20220128 |
| 50 | MP0001970_abnormal_pain_threshold | 1.19938400 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.19074537 |
| 52 | MP0000639_abnormal_adrenal_gland | 1.16858072 |
| 53 | MP0002184_abnormal_innervation | 1.16365454 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.08777243 |
| 55 | MP0004924_abnormal_behavior | 1.06302177 |
| 56 | MP0005386_behavior/neurological_phenoty | 1.06302177 |
| 57 | MP0003123_paternal_imprinting | 1.05914902 |
| 58 | MP0000427_abnormal_hair_cycle | 1.05450166 |
| 59 | MP0005253_abnormal_eye_physiology | 1.05303962 |
| 60 | MP0002089_abnormal_postnatal_growth/wei | 1.04025530 |
| 61 | MP0002734_abnormal_mechanical_nocicepti | 1.03861281 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.03283297 |
| 63 | MP0001270_distended_abdomen | 1.02039912 |
| 64 | MP0002067_abnormal_sensory_capabilities | 1.01383054 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 1.00893380 |
| 66 | MP0002735_abnormal_chemical_nociception | 0.99596386 |
| 67 | MP0004885_abnormal_endolymph | 0.98669310 |
| 68 | MP0000955_abnormal_spinal_cord | 0.98561167 |
| 69 | MP0001502_abnormal_circadian_rhythm | 0.98482807 |
| 70 | MP0002736_abnormal_nociception_after | 0.97446327 |
| 71 | MP0000538_abnormal_urinary_bladder | 0.97059073 |
| 72 | MP0002229_neurodegeneration | 0.96790828 |
| 73 | MP0001324_abnormal_eye_pigmentation | 0.95715550 |
| 74 | MP0002249_abnormal_larynx_morphology | 0.95175482 |
| 75 | MP0010386_abnormal_urinary_bladder | 0.93216400 |
| 76 | MP0004142_abnormal_muscle_tone | 0.92482955 |
| 77 | MP0002234_abnormal_pharynx_morphology | 0.91527520 |
| 78 | MP0004742_abnormal_vestibular_system | 0.91027451 |
| 79 | MP0002882_abnormal_neuron_morphology | 0.90047033 |
| 80 | MP0003567_abnormal_fetal_cardiomyocyte | 0.88961633 |
| 81 | MP0002752_abnormal_somatic_nervous | 0.88689597 |
| 82 | MP0003136_yellow_coat_color | 0.88628558 |
| 83 | MP0005085_abnormal_gallbladder_physiolo | 0.87944879 |
| 84 | MP0005670_abnormal_white_adipose | 0.86981835 |
| 85 | MP0002693_abnormal_pancreas_physiology | 0.85327245 |
| 86 | MP0002102_abnormal_ear_morphology | 0.85130264 |
| 87 | MP0005195_abnormal_posterior_eye | 0.83696378 |
| 88 | MP0003938_abnormal_ear_development | 0.82456191 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.82292653 |
| 90 | MP0000026_abnormal_inner_ear | 0.81952548 |
| 91 | MP0002233_abnormal_nose_morphology | 0.78245889 |
| 92 | MP0003633_abnormal_nervous_system | 0.76749637 |
| 93 | MP0002751_abnormal_autonomic_nervous | 0.75758615 |
| 94 | MP0002822_catalepsy | 0.74392617 |
| 95 | MP0004130_abnormal_muscle_cell | 0.74186470 |
| 96 | MP0002152_abnormal_brain_morphology | 0.73220891 |
| 97 | MP0005083_abnormal_biliary_tract | 0.72148887 |
| 98 | MP0003252_abnormal_bile_duct | 0.71147848 |
| 99 | MP0005332_abnormal_amino_acid | 0.71129825 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 0.70738951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperventilation (HP:0002883) | 3.68090133 |
| 2 | Nephronophthisis (HP:0000090) | 3.56083513 |
| 3 | Joint hemorrhage (HP:0005261) | 3.33167597 |
| 4 | Deep venous thrombosis (HP:0002625) | 3.18095892 |
| 5 | Epileptic encephalopathy (HP:0200134) | 3.16859229 |
| 6 | Focal seizures (HP:0007359) | 3.08126957 |
| 7 | Tubular atrophy (HP:0000092) | 3.07652968 |
| 8 | Pancreatic cysts (HP:0001737) | 3.05170311 |
| 9 | Lymphangioma (HP:0100764) | 3.03628656 |
| 10 | Abnormality of midbrain morphology (HP:0002418) | 2.95445306 |
| 11 | Molar tooth sign on MRI (HP:0002419) | 2.95445306 |
| 12 | Abnormality of the renal cortex (HP:0011035) | 2.91887900 |
| 13 | Abnormality of the renal medulla (HP:0100957) | 2.87697294 |
| 14 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.87133503 |
| 15 | Broad-based gait (HP:0002136) | 2.86774380 |
| 16 | Focal motor seizures (HP:0011153) | 2.82466235 |
| 17 | Rectal prolapse (HP:0002035) | 2.76228244 |
| 18 | Congenital stationary night blindness (HP:0007642) | 2.67407557 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 2.65893100 |
| 20 | Type II lissencephaly (HP:0007260) | 2.64489172 |
| 21 | Attenuation of retinal blood vessels (HP:0007843) | 2.52765915 |
| 22 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.50466232 |
| 23 | Pendular nystagmus (HP:0012043) | 2.48183920 |
| 24 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.48039171 |
| 25 | Vitreoretinal degeneration (HP:0000655) | 2.44889644 |
| 26 | Hypochromic anemia (HP:0001931) | 2.40680939 |
| 27 | Medial flaring of the eyebrow (HP:0010747) | 2.33847245 |
| 28 | Genetic anticipation (HP:0003743) | 2.33838246 |
| 29 | Gait imbalance (HP:0002141) | 2.32707770 |
| 30 | Concave nail (HP:0001598) | 2.31747668 |
| 31 | Severe muscular hypotonia (HP:0006829) | 2.30157205 |
| 32 | Lissencephaly (HP:0001339) | 2.26634474 |
| 33 | Stomatitis (HP:0010280) | 2.26366104 |
| 34 | Hyperglycinuria (HP:0003108) | 2.23448855 |
| 35 | Dialeptic seizures (HP:0011146) | 2.21569197 |
| 36 | Cerebellar dysplasia (HP:0007033) | 2.15978195 |
| 37 | Abolished electroretinogram (ERG) (HP:0000550) | 2.14758049 |
| 38 | Ketosis (HP:0001946) | 2.14724638 |
| 39 | Amblyopia (HP:0000646) | 2.12479619 |
| 40 | True hermaphroditism (HP:0010459) | 2.10832057 |
| 41 | Epidermoid cyst (HP:0200040) | 2.10479066 |
| 42 | Clumsiness (HP:0002312) | 2.08113353 |
| 43 | Agitation (HP:0000713) | 2.04709993 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04133093 |
| 45 | Absent speech (HP:0001344) | 2.03250044 |
| 46 | Cystic liver disease (HP:0006706) | 2.03185179 |
| 47 | Febrile seizures (HP:0002373) | 2.02733962 |
| 48 | Status epilepticus (HP:0002133) | 2.01398205 |
| 49 | Absent epiphyses (HP:0010577) | 2.01149807 |
| 50 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.01149807 |
| 51 | Congenital primary aphakia (HP:0007707) | 2.00580438 |
| 52 | Vaginal fistula (HP:0004320) | 2.00099433 |
| 53 | Broad alveolar ridges (HP:0000187) | 1.99878796 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.96194185 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 1.96194185 |
| 56 | Hepatoblastoma (HP:0002884) | 1.95911235 |
| 57 | Hyperglycinemia (HP:0002154) | 1.94325629 |
| 58 | Pachygyria (HP:0001302) | 1.93584616 |
| 59 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93459988 |
| 60 | Renovascular hypertension (HP:0100817) | 1.93287126 |
| 61 | Abnormality of the aortic arch (HP:0012303) | 1.92658613 |
| 62 | Abnormal pupillary function (HP:0007686) | 1.91684067 |
| 63 | Hypothermia (HP:0002045) | 1.91597721 |
| 64 | Polydipsia (HP:0001959) | 1.88715503 |
| 65 | Abnormal drinking behavior (HP:0030082) | 1.88715503 |
| 66 | Progressive cerebellar ataxia (HP:0002073) | 1.87290674 |
| 67 | Abnormality of the pubic bones (HP:0003172) | 1.85832693 |
| 68 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.85462047 |
| 69 | Renal hypoplasia (HP:0000089) | 1.85029054 |
| 70 | Hemiparesis (HP:0001269) | 1.82888730 |
| 71 | Anencephaly (HP:0002323) | 1.81701596 |
| 72 | Retinal atrophy (HP:0001105) | 1.81529890 |
| 73 | Xanthomatosis (HP:0000991) | 1.81198935 |
| 74 | Ketoacidosis (HP:0001993) | 1.78345793 |
| 75 | Abnormality of the vitreous humor (HP:0004327) | 1.78095658 |
| 76 | Pancreatic fibrosis (HP:0100732) | 1.77190692 |
| 77 | Rib fusion (HP:0000902) | 1.76156310 |
| 78 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.75115276 |
| 79 | Nephrogenic diabetes insipidus (HP:0009806) | 1.74880722 |
| 80 | Genital tract atresia (HP:0001827) | 1.74617646 |
| 81 | Methylmalonic aciduria (HP:0012120) | 1.73907260 |
| 82 | Hyperlipoproteinemia (HP:0010980) | 1.73032002 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.69095070 |
| 84 | Stage 5 chronic kidney disease (HP:0003774) | 1.67107975 |
| 85 | Hypoplastic ischia (HP:0003175) | 1.65650072 |
| 86 | Vaginal atresia (HP:0000148) | 1.65568097 |
| 87 | Increased intramyocellular lipid droplets (HP:0012240) | 1.65454354 |
| 88 | Hypophosphatemic rickets (HP:0004912) | 1.65088397 |
| 89 | Disproportionate short-trunk short stature (HP:0003521) | 1.65048750 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.64981683 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.64981683 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.64981683 |
| 93 | Anophthalmia (HP:0000528) | 1.64970378 |
| 94 | Retinal dysplasia (HP:0007973) | 1.63436059 |
| 95 | Inability to walk (HP:0002540) | 1.61988763 |
| 96 | Asplenia (HP:0001746) | 1.61263150 |
| 97 | Abnormality of the femoral head (HP:0003368) | 1.60461428 |
| 98 | Oligodontia (HP:0000677) | 1.60082788 |
| 99 | Increased corneal curvature (HP:0100692) | 1.59610543 |
| 100 | Keratoconus (HP:0000563) | 1.59610543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.35202682 |
| 2 | TNK2 | 3.31404402 |
| 3 | WNK4 | 2.81979329 |
| 4 | WNK3 | 2.65658277 |
| 5 | MARK1 | 2.65076258 |
| 6 | MAP4K2 | 2.52613691 |
| 7 | FGFR2 | 2.37632182 |
| 8 | NUAK1 | 2.34590581 |
| 9 | NTRK3 | 2.29304061 |
| 10 | INSRR | 2.21076178 |
| 11 | CASK | 2.17569663 |
| 12 | ADRBK2 | 2.11696469 |
| 13 | SIK2 | 1.98377361 |
| 14 | LATS1 | 1.97206760 |
| 15 | DYRK2 | 1.91224418 |
| 16 | MAP2K6 | 1.81755547 |
| 17 | MAP2K2 | 1.75109311 |
| 18 | PHKG1 | 1.71662526 |
| 19 | PHKG2 | 1.71662526 |
| 20 | NTRK2 | 1.71113620 |
| 21 | MAPK13 | 1.70889910 |
| 22 | MAP3K4 | 1.65512451 |
| 23 | EPHA4 | 1.63040829 |
| 24 | MAP3K7 | 1.51859903 |
| 25 | FGFR4 | 1.46316513 |
| 26 | PRKD3 | 1.44049309 |
| 27 | DYRK1A | 1.43523036 |
| 28 | TLK1 | 1.43291869 |
| 29 | PIK3CA | 1.42917068 |
| 30 | SIK1 | 1.33985808 |
| 31 | CDC42BPA | 1.25719071 |
| 32 | STK38L | 1.20651203 |
| 33 | GRK1 | 1.11306986 |
| 34 | DYRK1B | 1.08616667 |
| 35 | PKN2 | 1.04474309 |
| 36 | DAPK2 | 1.01541274 |
| 37 | PKN1 | 0.99412569 |
| 38 | MAP2K1 | 0.99017081 |
| 39 | BRSK1 | 0.98158239 |
| 40 | SGK494 | 0.97524601 |
| 41 | SGK223 | 0.97524601 |
| 42 | PRKCG | 0.96103813 |
| 43 | PAK3 | 0.94152322 |
| 44 | PINK1 | 0.91658857 |
| 45 | PRKCZ | 0.91385592 |
| 46 | TYRO3 | 0.87317943 |
| 47 | PRKAA1 | 0.84122220 |
| 48 | STK16 | 0.84001561 |
| 49 | ERBB2 | 0.83533788 |
| 50 | BCKDK | 0.82001841 |
| 51 | TRIB3 | 0.81538704 |
| 52 | CAMK1D | 0.81535670 |
| 53 | NME1 | 0.81369582 |
| 54 | FGFR3 | 0.80464654 |
| 55 | CCNB1 | 0.75932746 |
| 56 | CAMK1 | 0.74344649 |
| 57 | BRD4 | 0.74263679 |
| 58 | MAP2K4 | 0.72669450 |
| 59 | NEK9 | 0.69479172 |
| 60 | ICK | 0.68881122 |
| 61 | CAMK4 | 0.67021083 |
| 62 | CAMKK1 | 0.63431830 |
| 63 | STK11 | 0.63267707 |
| 64 | PRKD2 | 0.61259412 |
| 65 | CSNK1D | 0.60139525 |
| 66 | MUSK | 0.59732123 |
| 67 | STK39 | 0.57337564 |
| 68 | MAPK15 | 0.53313471 |
| 69 | RET | 0.53307137 |
| 70 | PRKCI | 0.53128039 |
| 71 | LIMK1 | 0.51666589 |
| 72 | ITK | 0.50836388 |
| 73 | MARK2 | 0.50181329 |
| 74 | HIPK2 | 0.49969301 |
| 75 | ERBB3 | 0.49417084 |
| 76 | STK38 | 0.48139056 |
| 77 | ADRBK1 | 0.47074065 |
| 78 | CAMK2A | 0.47011318 |
| 79 | PRKAA2 | 0.45688650 |
| 80 | CDK5 | 0.45397370 |
| 81 | GRK5 | 0.45301228 |
| 82 | PRKCE | 0.44822630 |
| 83 | MAPK12 | 0.43631640 |
| 84 | FGFR1 | 0.43310495 |
| 85 | PRKACA | 0.42669882 |
| 86 | CSNK1G3 | 0.42228203 |
| 87 | ROCK1 | 0.41746661 |
| 88 | CSNK1A1L | 0.41597303 |
| 89 | WNK1 | 0.41356890 |
| 90 | TNIK | 0.41338553 |
| 91 | SGK1 | 0.41141305 |
| 92 | OXSR1 | 0.40263787 |
| 93 | FER | 0.39594050 |
| 94 | CAMK1G | 0.39009173 |
| 95 | CAMK2B | 0.38534325 |
| 96 | CSNK1G1 | 0.37408002 |
| 97 | MINK1 | 0.37255850 |
| 98 | PLK4 | 0.35028550 |
| 99 | PRKG1 | 0.34413681 |
| 100 | CHUK | 0.34203354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.04213920 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.39494954 |
| 3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.29059838 |
| 4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.29008251 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.15177814 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.14481825 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.13004899 |
| 8 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.01543049 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.99981141 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 1.99712469 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97423010 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95998320 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94574501 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93751355 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.86078472 |
| 16 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.81772173 |
| 17 | ABC transporters_Homo sapiens_hsa02010 | 1.79019711 |
| 18 | Lysine degradation_Homo sapiens_hsa00310 | 1.73539535 |
| 19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.69017128 |
| 20 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.65574170 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.58511486 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.58418461 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.56186927 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.52068400 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42817632 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.37187606 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.35298342 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.28555460 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.27281741 |
| 30 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.23443193 |
| 31 | Circadian entrainment_Homo sapiens_hsa04713 | 1.22841330 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.19172862 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19030285 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.18758974 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16610240 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14921134 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.12591233 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.11193830 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10883771 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.09339385 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 1.07483930 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06132165 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.02191340 |
| 44 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.99892582 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97574121 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 0.95582734 |
| 47 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.93793894 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93496214 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.92595696 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91125960 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.90714353 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89838663 |
| 53 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89389819 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88137439 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83835039 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83565680 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81789440 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81667967 |
| 59 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79621465 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 0.79097242 |
| 61 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.75505338 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73803758 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.70924908 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70044750 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69211253 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.68343707 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67581106 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65734919 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63659318 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62447202 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61516986 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61450785 |
| 73 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.61242105 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60920100 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60307520 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59681040 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57354669 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56515739 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56067543 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55452387 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55210986 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55129761 |
| 83 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.54253440 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53369292 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51632409 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50233874 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50144734 |
| 88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49438742 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49364797 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49123351 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.48968022 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.44927781 |
| 93 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44548858 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44314043 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43612269 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.43349775 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42941779 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.42657795 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41788597 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39990472 |

